Pharmaceutical Technology1h
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
Drinks4h
Pernod Ricard cuts sales forecast
French spirits giant Pernod Ricard is now expecting its annual net sales to fall on an organic basis, the company said today ...
Pharmaceutical Technology6h
USPTO grants patent to Vistagen’s neuropathic pain treatment
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
verdictfoodservice23h
Olo partners FreedomPay for in-restaurant payments
Restaurant technology solution provider Olo has partnered FreedomPay to expedite the adoption of in-restaurant payments in ...